Freshfields Bruckhaus Deringer and Clifford Chance (CC) are among a number of firms advising on Swedish private equity group EQT’s €1.8bn (£1.5m) purchase of Germany’s BSN medical, reports The Am Law Daily.
EQT secured the deal after reaching an agreement with company management and Montagu Private Equity, which acquired the medical device company for roughly €880m (£700m) in 2005.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
